A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CRINECERFONT (NBI-74788) IN PEDIATRIC SUBJECTS WITH CLASSIC CONGENITAL ADRENAL HYPERPLASIA, FOLLOWED BY OPEN-LABEL TREATMENT
- Registry ID
- NBI-74788-CAH2006
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- NEUROCRINE BIOSCIENCES INC
- Start date
- 2021-09-27
- Last update
- 2021-03-30
Conditions
- CONGENITAL ADRENAL HYPERPLASIA
View on source registry